From Sample to Result Image: A Complete Workflow Breakdown of an mIHC Project
For researchers conducting tumor immunology and microenvironment mechanism studies, multiplex immunofluorescence immunohistochemistry (mIHC) is virtually unavoidable. However, most people's understanding of mIHC is limited to the final effect images with clear colors and exquisite layouts, as well as quantitative statistical charts in papers. They don't realize that a top-tier mIHC image and a set of data suitable for SCI publication are backed by a complete, rigorous, complex, and interlocking standardized experimental pipeline.

Many researchers have fallen into the same misconception: as long as the sections are successfully stained, usable research results can be produced. But real mIHC experiments are never "finished after staining." From an ordinary tissue sample to a complete, precise, and publishable data system, every step requires strict quality control. Any oversight in any link will cause staining distortion, data deviation, and spatial information failure, ultimately rendering the entire experiment useless and the paper data unusable.

This article will guide you through the core steps of an mIHC project from raw sections to top-tier journal figures, helping you thoroughly understand the research logic and application value of mIHC.
1. Sample Preparation: The Core Starting Point That Determines the Upper Limit of the Experiment
The success or failure of all mIHC experiments is already determined from the moment the sample is processed. Compared with ordinary single-marker IHC, mIHC relies on the core advantage of simultaneous detection of multiple markers within the same tissue space, imposing requirements on sample quality that are several times more stringent. Tissue integrity, antigen preservation status, and section uniformity directly determine subsequent signal consistency and spatial information accuracy, forming the cornerstone of the entire experiment.
The core tasks of this stage include:
  • Basic Sample Preparation: Standardized processing of FFPE paraffin tissues and frozen tissues to ensure complete tissue morphology and intact antigen preservation.

  • Section Scheme Design: Planning serial sections or tissue microarrays (TMA) according to research needs to avoid sample bias.

  • Pre-Quality Verification: Screening for section wrinkles, detachment, and impurities, confirming intact antigen preservation in tissues.

  • Custom Panel Design: Customizing marker combinations based on research targets.

Taking the popular tumor immune microenvironment research as an example, a mature custom panel will precisely cover multi-dimensional core indicators including tumor localization, immune infiltration, immune escape, and macrophage polarization, such as CK, CD3/CD8, PD-1/PD-L1/FOXP3, CD68/CD163, etc. High-quality panel design combined with qualified sample quality is the core prerequisite for producing valid biological conclusions.
2. Pilot Experiment Exploration: The Critical Pre-Step from Tissue QC to Antibody Optimization
Before formally conducting mIHC multiplex staining, pilot experiments are crucial for ensuring experimental success rate and data stability. mIHC belongs to a multi-round cyclic staining system and is highly sensitive to tissue substrate quality and antibody working concentrations. Once the initial sample or antibody conditions are not met, all subsequent staining, imaging, and data analysis will suffer from systematic errors, rendering the entire experiment invalid. Therefore, all formal experimental conditions must be explored and finalized in advance through pilot experiments.
HE Staining: Gold Standard Assessment of Tissue Quality
Perform routine HE staining on all samples to be tested, observe tissue morphology under the microscope, confirm that the wax block embedding area and section sampling site are consistent with the target tissue area, and comprehensively evaluate key indicators such as sampling status, tissue dehydration, paraffin embedding, and section flatness. Strictly screen qualified samples with intact tissue morphology, clear structure, no large-scale necrosis, and no wrinkles or detachment, eliminating samples with substrate defects to avoid staining unevenness, weak signals, and abnormal background caused by tissue quality issues from the source.
Primary Antibody IHC Gradient Pilot Experiment: Locking the Optimal Working Concentration
To avoid non-specific background, signal quenching, and false negative/positive results in mIHC cyclic staining, primary antibody concentration gradient exploration must be completed in advance on positive tissue sections. The experiment uniformly sets three concentration gradients (low, medium, high) for parallel staining, compares and analyzes signal specificity, positive expression intensity, and background cleanliness across groups, and finally screens out the antibody working concentration with the optimal signal-to-noise ratio and strongest specificity, standardizing the experimental system to provide a stable and reproducible experimental foundation for subsequent multi-marker cyclic mIHC staining.
3. Multiplex Staining: In-Situ Precise Loading of Multi-Dimensional Biological Information
Many researchers hold a typical misconception: they believe mIHC is simply the superposition of multiple fluorescent colors. In fact, the core value of mIHC multiplex staining is by no means a mere visual effect, but the precise superposition of biological information from multiple targets within the same tissue in-situ, maximizing the restoration of the true tumor microenvironment state.
The entire staining process is a cyclic precision operation with quality control at every step:
Tissue Section Preprocessing → Antigen Retrieval → Primary Antibody Specific Incubation → HRP-Conjugated Secondary Antibody Binding → TSA Tyramide Fluorescence Signal Amplification → Antibody Stripping → Multi-Marker Cyclic Detection → DAPI Nuclear Staining Finalization
Each round of staining, stripping, and signal amplification requires precise control of temperature, duration, and reagent concentration, ensuring clear and robust signals for each target while completely avoiding issues such as antibody cross-interference, signal quenching, and non-specific staining.
4. Scanning Imaging: Converting Fluorescent Signals into Standardized Digital Data
Completed staining does not equal usable experimental images. Images observed with the naked eye or captured by ordinary microscopes have insufficient resolution and standardization levels and cannot be used for SCI paper publication. The core significance of this step is to convert visual fluorescent signals into standardized digital images that can be permanently stored, precisely quantified, and deeply analyzed through whole-slide panoramic digital scanning, laying a solid foundation for subsequent data analysis.
Imaging must strictly adhere to three standards throughout:
  • Whole-slide panoramic imaging with no field-of-view omissions and no edge artifacts

  • Multi-channel fluorescence simultaneous acquisition with precise matching of each target's fluorescence wavelength band

  • High-resolution digital archiving preserving extreme detail for subsequent refined analysis

Simultaneously strictly control core indicators such as signal intensity, background noise, channel crosstalk, and image clarity. Obtaining high-quality original digital images is the core prerequisite for accurate and error-free subsequent quantitative analysis results.
5. Spectral Unmixing: Eliminating Signal Confusion and Restoring Pure Single-Target Signals
Multiplex fluorescence staining naturally presents technical challenges: spectral overlap of different fluorescent dyes and tissue autofluorescence interference directly lead to signal confusion and blurred boundaries in raw images, making it impossible to accurately distinguish the true expression of each target. This is also the core reason why many independently conducted mIHC experiments ultimately produce inaccurate data, unreproducible results, and require paper revisions.
Spectral unmixing (spectral deconvolution) is precisely the core key step to solve this problem and achieve mIHC data precision. Through professional algorithms, mixed fluorescence signals are intelligently disassembled and separated, accurately eliminating tissue autofluorescence background and channel crosstalk interference, precisely decomposing a complex multi-color original image into independent, pure, and accurate single-channel images for each target.
Exclusive images for CK tumor channel, CD8 T cell channel, PD-L1 immune target channel, DAPI nuclear staining channel, etc., can be independently output with pure signals and precise localization, completely eliminating experimental errors caused by signal superposition and clearing obstacles for subsequent refined data analysis.
6. Image Analysis: From Subjective "Looking at Images" to Objective "Reading Data"
mIHC images without professional analysis have only visual display value, not scientific argumentation value. Traditional experiments can only rely on subjective visual judgment of "more/fewer positive cells, deep/shallow infiltration," resulting in vague conclusions lacking persuasiveness and unable to support SCI paper arguments. In contrast, standardized mIHC image analysis completely breaks away from subjective prediction, achieving comprehensive quantification, visualization, and precise analysis.
Two core dimensions of data can be precisely output at this stage:
Data CategoryDetection Content
Basic QuantificationPrecise cell identification, positive cell counting, positive rate statistics, fluorescence expression intensity analysis
Core Spatial AnalysisCell co-localization determination, intercellular spatial distance measurement, immune cell aggregation characteristic analysis
This is also the core scientific value that distinguishes mIHC from traditional IHC: it can not only qualitatively answer "what cells are present," but also quantitatively and spatially answer "where the cells are, how they are distributed, and how they interact with each other." Key mechanism questions such as whether CD8+ T cells effectively infiltrate the tumor core region, whether PD-L1-positive cells form close immune interactions with T cells, and whether immune cells exhibit specific spatial aggregation can all be answered precisely, objectively, and traceably through quantitative analysis.
No Need to Explore Everything Yourself — EnkiLife One-Stop Complete mIHC Research Service
From early Panel design, experimental condition optimization, and multiplex cyclic staining, to mid-stage high-definition scanning imaging, and late-stage refined image analysis, every step is interlocking and mutually constraining. Any detail mistake will lead to signal distortion, invalid data, and complete experimental rework, wasting substantial samples, time, and research funds. Addressing the pain points of researchers including tedious experiments, technical limitations, substandard data, non-compliant figures, and repeated revisions, EnkiLife launches a one-stop mIHC full-process research service.
No need to build complex experimental systems yourself, no need to repeatedly explore experimental parameters, no need to spend substantial time processing data and optimizing figures. The professional team handles everything throughout, efficiently delivering publishable results.

   💬 WhatsApp